Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (52)

Company Market Cap Price
TMO Thermo Fisher Scientific Inc.
Thermo Fisher provides contract manufacturing services (CMO capabilities) including sterile fill-finish and related manufacturing.
$214.25B
$567.41
+2.01%
PFE Pfizer Inc.
Pfizer CenterOne represents Pfizer's contract manufacturing capabilities, aligning with the Contract Manufacturing Organizations theme.
$140.14B
$24.66
+1.50%
CAH Cardinal Health, Inc.
CAH provides contract drug manufacturing services via BioPharma Solutions.
$45.55B
$190.72
+0.46%
A Agilent Technologies, Inc.
BIOVECTRA acquisition expands Agilent's contract manufacturing capabilities (CDMO) for advanced modalities.
$41.58B
$146.35
+2.09%
JBL Jabil Inc.
Aseptic filling and dry oral dosage capabilities via Pharmaceutics International (Pii) reflect contract manufacturing services in pharma.
$23.71B
$220.91
-0.25%
WST West Pharmaceutical Services, Inc.
West generates revenue from contract manufacturing services, moving towards higher-margin opportunities.
$20.28B
$282.21
+1.32%
RDY Dr. Reddy's Laboratories Limited
Active Contract Manufacturing Organization (CDMO) capabilities through PSAI, including APIs and biologics manufacturing.
$11.09B
$13.30
-1.12%
CRL Charles River Laboratories International, Inc.
CRL provides manufacturing solutions (CDMO-like capabilities) for microbial and biologics-related processes as part of its services.
$8.84B
$180.13
+0.57%
ATR AptarGroup, Inc.
Acquisitions like Mod3 Pharma expand Aptar Pharma services into contract manufacturing (CDMO) capabilities.
$7.64B
$115.98
-6.73%
AMRX Amneal Pharmaceuticals, Inc.
Manufacturing scale and proposed CMOs for peptide, injectables, and biosimilars support external manufacturing services.
$3.39B
$10.82
+8.20%
ITGR Integer Holdings Corporation
Integer is a contract development and manufacturing organization (CDMO) for medical devices, directly providing design, development and manufacturing services to OEMs.
$2.26B
$64.53
+1.91%
GLPG Galapagos N.V.
DMU-based manufacturing capability with partnerships; aligns with contract manufacturing services (CMO-like).
$2.09B
$31.78
+1.40%
ANIP ANI Pharmaceuticals, Inc.
ANI provides contract manufacturing and related services for several products (Generics/Brands), aligning with Contract Manufacturing Organizations.
$1.96B
$90.62
-1.42%
AUPH Aurinia Pharmaceuticals Inc.
Aurinia provides manufacturing capacity/services (e.g., Monoplant) to support production, i.e., contract manufacturing organizations.
$1.78B
$13.18
+8.70%
PGEN Precigen, Inc.
Exemplar subsidiary provides contract manufacturing services, aligning with Contract Manufacturing Organizations.
$1.22B
$4.14
+2.35%
EMBC Embecta Corp.
Embecta provides contract manufacturing/partner manufacturing services and potential co-packaging arrangements.
$779.62M
$13.34
-2.34%
MGTX MeiraGTx Holdings plc
Vertically integrated manufacturing capabilities and third-party supply for Johnson & Johnson indicate CDMO-like manufacturing services.
$729.72M
$9.07
+3.89%
KE Kimball Electronics, Inc.
Strategic expansion into Contract Manufacturing Organizations for medical devices aligns with KE's Medical CMO focus.
$708.86M
$29.04
-0.72%
EBS Emergent BioSolutions Inc.
Emergent's specialized, large-scale manufacturing network for drug substances/products supports core MCM/NARCAN production; aligns with contract manufacturing capabilities.
$665.82M
$12.48
-2.80%
STKL SunOpta Inc.
The company functions as a co-manufacturer and private label partner, providing manufacturing services to brands and retailers.
$613.57M
$5.22
-1.42%
TKNO Alpha Teknova, Inc.
Teknova provides GMP-grade manufacturing for clinical-relevant reagents and custom solutions, aligning with contract manufacturing services.
$280.56M
$5.25
+3.66%
LFCR Lifecore Biomedical, Inc.
Lifecore is a pure-play CDMO focused on sterile injectable drug development and manufacturing.
$266.21M
$7.18
+1.13%
CNFN CFN Enterprises Inc.
CNFN's Ranco segment operates as a contract manufacturer/co-packer and white-label producer for clients.
$255.19M
$2.15
SLSN Solesence, Inc. Common Stock
Solésence operates as a contract development and manufacturing organization (CDMO) for beauty products, matching Contract Manufacturing Organizations.
$229.24M
$3.56
+8.54%
CDXS Codexis, Inc.
Management's pursuit of CDMO partnerships and aim to supply siRNA materials positions Codexis within contract manufacturing/CMO capabilities.
$196.34M
$2.36
PLX Protalix BioTherapeutics, Inc.
Protalix provides drug substance production for partners (e.g., Pfizer, Fiocruz, Chiesi), acting as a contract manufacturer for biologics.
$188.67M
$2.37
+4.87%
BHST BioHarvest Sciences Inc. Common Stock
BioHarvest operates a CDMO division providing contract development and manufacturing services for plant-based compounds.
$155.08M
$8.80
-9.84%
MCRB Seres Therapeutics, Inc.
Seres provided manufacturing services for the VOWST business under a transition services agreement, effectively acting as a contract manufacturer (CMO) for that product.
$140.59M
$15.88
+0.67%
XTNT Xtant Medical Holdings, Inc.
Xtant operates as an OEM/contract manufacturer for orthobiologic and implant products.
$122.53M
$0.87
-4.90%
ACNT Ascent Industries Co.
Custom manufacturing / contract manufacturing services.
$121.72M
$12.17
+0.25%
MGNX MacroGenics, Inc.
Maintains a manufacturing facility and provides contract manufacturing services.
$104.73M
$1.65
+3.45%
COSG Cosmos Group Holdings Inc.
Cana Laboratories' facility upgrades and a 5-year Pharmex contract manufacturing agreement indicate COSG's direct contract manufacturing service in pharma.
$91.72M
$0.02
NTRB Nutriband Inc.
Contract development and manufacturing services through Pocono Pharmaceuticals (transdermal/topical products), i.e., a CDMO.
$75.07M
$6.67
-3.55%
ETST Earth Science Tech, Inc.
ETST's core pharmaceutical operations include compounding pharmacies (RxCompound, Mister Meds) providing outsourced drug manufacturing services.
$69.63M
$0.24
ABVC ABVC BioPharma, Inc.
BioKey's manufacturing of clinical trial materials aligns with Contract Manufacturing Organizations activities.
$46.97M
$2.77
-1.77%
CELU Celularity Inc.
The company monetizes its manufacturing capabilities by offering contract development/manufacturing services to third parties.
$46.70M
$1.94
+2.38%
OTLC Oncotelic Therapeutics, Inc.
JV-based GMP manufacturing capability provides in-house/partner contract manufacturing for clinical materials.
$38.62M
$0.10
JANL Janel Corporation
Life Sciences subsidiaries provide contract manufacturing services (antibody/reagent production, viral vector production).
$37.96M
$32.00
DSY Big Tree Cloud Holdings Limited
Provides OEM/ODM manufacturing services, i.e., contract manufacturing for others.
$34.81M
$0.59
-2.89%
IGC IGC Pharma, Inc.
White-label/contract manufacturing revenue stream indicating external manufacturing services.
$33.16M
$0.40
-0.60%
PLUR Pluri Inc.
PluriCDMO provides cell-therapy manufacturing services, generating revenue and serving as a core business line.
$30.55M
$3.99
+2.57%
COSM Cosmos Health Inc.
Owns/operates in-house EU GMP manufacturing via Cana Laboratories Holdings Cyprus Ltd. and Cana S.A., enabling contract manufacturing revenue.
$23.29M
$0.81
-9.93%
STCB Starco Brands, Inc.
Vertical integration via acquisition of The Starco Group provides contract manufacturing capabilities.
$21.17M
$0.03
NXGL NEXGEL, Inc.
NXGEL generates revenue from contract manufacturing of hydrogel-based medical and consumer products.
$18.83M
$2.46
-1.41%
NAII Natural Alternatives International, Inc.
Direct contract manufacturing services for private-label vitamins, minerals, herbal and other health care products.
$16.84M
$2.67
-2.20%
LGVN Longeveron Inc.
The company is pursuing and expanding contract manufacturing/CDMO revenue as a direct service offering.
$12.51M
$0.83
-0.57%
BGLC BioNexus Gene Lab Corp.
Chemrex pivot to biotech-focused CDMO activities positions it as a Contract Manufacturing Organization.
$9.74M
$5.38
+3.66%
BMRA Biomerica, Inc.
Offers Contract Manufacturing services with notable growth, i.e., contract manufacturing revenue stream.
$7.85M
$2.74
-0.72%
DQWS DSwiss, Inc.
DQWS provides turnkey OEM/ODM contract manufacturing services for health care, beauty, and nutraceutical products.
$6.62M
$0.03
SXTC China SXT Pharmaceuticals, Inc.
SXTC manufactures TCMP products and operates GMP-compliant production lines, consistent with a contract manufacturing organization (CMO) model.
$5.55M
$1.37
+0.74%
BIOE Bio Essence Corporation
Provides outsourced contract manufacturing (OEM) services for health-related products.
$2.70M
$0.07
SMFL Smart for Life, Inc.
SMFL owns manufacturing facilities (BSNM and DSO) and provides contract manufacturing for branded and contract-made nutraceutical products.
$1366
$0.01

Loading company comparison...

Loading research report...

COSM Cosmos Health Inc.

Cosmos Health Launches Nanotechnology R&D Program to Boost Nutraceutical Efficacy

Oct 31, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Reports Q3 2025 Results and Saffron Tech Partnership

Oct 30, 2025
LFCR Lifecore Biomedical, Inc.

Lifecore Biomedical and PolyPeptide Laboratories Announce End‑to‑End Peptide Manufacturing Collaboration

Oct 28, 2025
ITGR Integer Holdings Corporation

Integer Holdings Names Payman Khales as New President and CEO

Oct 25, 2025
CRL Charles River Laboratories International, Inc.

Charles River Laboratories Announces ADC Development Collaboration with Francis Crick Institute

Oct 24, 2025
ITGR Integer Holdings Corporation

Integer Holdings Corporation Reports Strong Third Quarter 2025 Results

Oct 24, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Reports Third‑Quarter 2025 Results

Oct 23, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Achieves Large-Scale Production of Plant-Based Exosomes

Sep 10, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Files Shelf Registration for Potential Equity Offering

Aug 24, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Reports Q2 2025 Revenue Growth and Gross Margin Expansion

Aug 11, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Reports Strong Q2 2025 Results and Significantly Raises Full-Year Guidance

Jul 24, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Appoints Robert McMahon as New Chief Financial Officer

Jul 21, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Expands VINIA SuperFood Teas with K-Cup Compatible Pods

Jun 30, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Dropped from Multiple Russell Growth Indices

Jun 30, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Active Lifestyles

Jun 04, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Enters Fragrance Market with New CDMO Contract for Plant-Based Compound

May 21, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Reports Strong Q1 2025 Revenue, Exceeding Guidance

May 15, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences' Pharmaceutical CDMO Project Advances to Stage 2, Validating Botanical Synthesis Platform

May 12, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Announces CFO Retirement and New Chief Proprietary Segment Officer Appointment

Apr 24, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Reports Strong Q4 and Full Year 2024 Financial Results, Doubles Annual Revenue

Mar 31, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences' Olive Cell Compound Shows Promise in Reducing Liver Fat Accumulation

Mar 04, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences' Flagship VINIA Product Surpasses $50 Million in Cumulative Sales

Feb 18, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Reports Q4 and Full-Year 2024 Results, Issues Disappointing 2025 Guidance

Feb 13, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Appoints Technology Veteran Sharon Malka to Board of Directors

Jan 22, 2025
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Introduces Daikyo PLASCAP® RUV Closures in New Nested Format

Jan 22, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences CEO Highlights Transformative 2024 and Outlines 2025 Growth Strategy

Jan 08, 2025
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Partners with Tate & Lyle to Develop Next-Generation Plant-Based Sweeteners

Dec 11, 2024
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Elects Janet Haugen to Board of Directors

Dec 11, 2024
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Reports Strong Q3 2024 Results and Launches VINIA SuperFood Functional Teas

Nov 25, 2024
BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Begins Trading on Nasdaq Global Market Under "BHST"

Nov 12, 2024
WST West Pharmaceutical Services, Inc.

West Pharmaceutical Services Reports Solid Q3 2024 Results and Raises Full-Year Guidance

Oct 24, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks